Hopes (and Stock Valuations) Tumble As New Herpesvirus Drug Tanks
Brincidofovir, better known to many in the chronic fatigue syndrome (ME/CFS) community as CMX001 tanked in its large Phase III trial. To say such a result was unexpected would be understating things. A lipid forumulated version...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.